A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Biochemical failure after treatment (defined as nadir PSA value + 2 ng/dl documented in the postoperative period).
3-6 months intervals during the first 2 years after the completion of the procedure and yearly thereafter unless is amended by the treating physician
No
Al Barqawi, MD
Study Chair
University of Colorado, Denver
United States: Institutional Review Board
06-1040
NCT00824928
January 2007
December 2014
Name | Location |
---|---|
Barbara Ann Karmanos Cancer Institute | Detroit, Michigan 48201 |
Medical University of South Carolina | Charleston, South Carolina 29425-0721 |
Rush University Medical Center | Chicago, Illinois 60612-3824 |
Indiana University Melvin and Bren Simon Cancer Center | Indianapolis, Indiana 46202-5289 |
Urology Associates of North Texas | Arlington, Texas 76015 |
University of Tennessee Cancer Institute - Memphis | Memphis, Tennessee 38104 |
Lakeland Regional Cancer Center | Lakeland, Florida 33805 |
Kaiser Permanente | Sacramento, California |
Loma Linda University | Loma Linda, California 92354 |
University of Colorado at Denver and Health Sciences Center | Aurora, Colorado 80045-0511 |
Urology of Virginia, Sentara Medical Group | Norfolk, Virginia 23503 |
Prostate Institute of America | Ventura, California 93003 |
Midwest Urology/RMD Clinical Research | Melrose Park, Illinois 60160 |
Methodist Hospital | Brooklyn, New York 11215 |
Nelson Stone (private practice) | New York, New York 10021 |
Riverside Urology, Inc. | Columbus, Ohio 43214 |
Rhode Island Hospital/Warren Alpert Medical School of Brown University | Providence, Rhode Island 02904 |